Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment.  The current Payment Percentage is 60%.

Halliburton or Non-Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma  (Level VIII)
$60,718.95
Lung Cancer 1 (Level VII)
$9,872.14
Other Cancer  (Level V)
$8,492.16
Severe Asbestosis  (Level IV)
$9,978.29
Asbestosis/Pleural Disease (Level III)
$2,547.65
Asbestosis/Pleural Disease (Level II)
$1,167.67
Other Asbestos Disease (Level I)
$106.15

 

Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma (Level VIII)
$144,897.50
Lung Cancer 1 (Level VII)
$47,662.25
Other Cancer (Level V)
$25,476.48
Severe Asbestosis (Level IV)
$31,314.84
Asbestosis/Pleural Disease (Level III)
$7,642.95
Asbestosis/Pleural Disease (Level II)
$4,033.78
Other Asbestos Disease (Level I)
$318.46